ICON plc : ICON Medical Imaging Rated as Top Provider in Imaging Industry Survey
November 17, 2011 at 05:50 am EST
By
Share
Respondents Chose ICON as the Vendor They Are Most Likely
to Work With in the Future
ICON today announced that its Medical Imaging division
was rated as the top provider of imaging services
according to an industry survey conducted by Blue Pyramid
Consulting, an affiliate of the Avoca Group.
According to the survey results, ICON Medical Imaging was
ranked 1st as the provider most likely to be chosen for
future projects. ICON Medical Imaging also received the
highest overall ranking for service provider attributes,
including operational excellence, technology,
scientific/therapeutic expertise, customer
responsiveness, value, reputation, financial stability
and ability to bundle services. For therapeutic
expertise, ICON was voted the leading imaging provider
for oncology, cardiovascular and device studies.
Ted Gastineau, President, ICON Medical Imaging, said "We
are delighted with the Blue Pyramid survey results and
they reflect the dedication of our team in bringing
together innovative technology and a customer service
model that ensures quality results on every study. Our
technology, medical and regulatory expertise have helped
clients to accelerate decision-making for many years and
we will continue to help them realise the benefits of
imaging services across all therapeutic areas and phases
of development."
The Blue Pyramid Consulting survey was developed to gain
an insight into the drivers for selecting medical imaging
core laboratory providers for clinical research. The
online survey was conducted in the first quarter of 2011
and responses were collected from 133 professionals from
pharmaceutical, biotech, medical device, not for profit
and academic institutions.
Blue Pyramid Consulting
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.